| Patent application number | Description | Published |
|---|
| 20090221559 | BENZODIAZEPINES AS HCV INHIBITORS - The present invention relates to the use of benzodiazepines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to benzodiazepine compounds per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents. | 09-03-2009 |
| 20090247523 | CARBOXAMIDE 4-[(4-PYRIDYL)AMINO]PYRIMIDINES USEFUL AS HCV INHIBITORS - The present invention relates to the use of carboxamide 4-[(4-pyridyl)amino]-pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. | 10-01-2009 |
| 20100041728 | HCV INHIBITING MACROCYCLIC PHENYLCARBAMATES - Compounds of the formula 1: | 02-18-2010 |
| 20100113440 | PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS - Compounds of the Formula (I) including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof; useful as HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient. | 05-06-2010 |
| 20110230436 | Uracyl Cyclopropyl Nucleotides - Compounds of the formula I: | 09-22-2011 |
| 20120034678 | Diaryl Ethers - Compounds of the formula I: | 02-09-2012 |
| 20120135953 | Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors - Inhibitors of HCV replication of formula I | 05-31-2012 |
| 20120136027 | Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors - Inhibitors of HCV replication of formula I | 05-31-2012 |
